Enrolling the wrong patients is a serious protocol deviation that leads to costly rework and delays, and increases risk to patient safety, data integrity and regulatory approval. The FDA's December ...
WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of PatroLabTM, a state-of-the-art digital twin platform ...
As a staff writer for Forbes Advisor, SMB, Kristy helps small business owners find the tools they need to keep their businesses running. She uses the experience of managing her own writing and editing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback